MHYOSPHERE®PCV ID: ESPHM Publications 2021
MHYOSPHERE® PCV ID is the first and only vaccine based on a recombinant Mycoplasma hyopneumoniae (M. hyo) strain, called Nexyhon. This strain expresses the capsid proteins of Porcine Circovirus Type 2 (PCV2) in its cytoplasm and acts as the only active substance as a whole once inactivated. Furthermore, it was the first vaccine registered in Europe with demonstrated protection against all three PCV2 genotypes (a, b and d).References | ||||
---|---|---|---|---|
1. Montané, J.; Simon-Grifé, M.; Moros, A.; Puigvert, E.; González-González, L.; Pedernera, C.; Acal, L.; Sitjà, M.: Duration of immunity of a novel intradermal vaccine against Mycoplasma hyopneumoniae and PCV2 infection, ESPHM 2021, IMM-PP-25. | ||||
2. Montané, J.; Simon-Grifé, M.; Moros, A.; Puigvert, E.; González-González, L.; Pedernera, C.; Acal, L.; Sitjà, M.: Efficacy of a new intradermal vaccine against Mycoplasmahyopneumoniae and PCV2 infection. ESPHM 2021, IMMPP-29 | ||||
3. Puig, A.; Perozo, E.; Sabaté, D.; Moros, A.; Roura, F.; March, R.; Montané, J.; Effect of Mhyosphere® PCV ID on the gowth performance under field conditions, ESPHM 2021, IMM-PP-20. | ||||